Why weren't they replicated to Cohort A though? It was only when IMU geniusly combined it with IL-2 that these exceptional result were seen so it kind of looks like Azer-Cel dropped the ball and sold potentially their most valuable IP very cheaply. And wasn't there talk of toxicity from these previous clinical trial sponsored by Azer-Cel????
Why weren't they replicated to Cohort A though? It was only when...
-
- There are more pages in this discussion • 741 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.002(4.35%) |
Mkt cap ! $360.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.9¢ | 4.6¢ | $892.6K | 18.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 3985725 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 407240 | 3 |
View Market Depth
| Last trade - 14.08pm 11/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |